Precision Therapy Based on Immune Microenvironment by Transcriptome Sequencing of Osteosarcoma, a Prospective, Multi-cohort Exploratory Clinical Study

Clinical trial NCT06776198 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06776198
Sponsor: Peking University People's Hospital
Status: NOT_YET_RECRUITING
Study type: OBSERVATIONAL

Osteosarcoma Transcriptome Tumor Microenvironment Precision Medicine

Start date: 2025-03-01
Primary completion: 2026-03-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.